Research Radar archive
What the system was watching on June 29, 2026
Frozen snapshot — captured at . This page does not refresh. Live view: today's Radar.
AI stock ideas
AI stock ideas
Short-term ideas with entry date, tracking window, and public outcome.
DatedTrackedOutcome visibleResearch only
| Ticker | Catalyst | Window | Status | Link |
|---|---|---|---|---|
BB BlackBerry Limited Technology | Strong short-term momentum candidate: stock is up about 36% over 21 trading days after a breakout, supported by Q1 fiscal 2027 revenue growth of 26% YoY, adjusted EBITDA up 144%, positive GAAP net income for a fifth straight quarter, estimate beats, raised guidance, and expanded government/product relationships. | Jun 29 – Jul 6 | Active (as of archive) | Open |
VLO Valero Energy Corporation Energy | Energy momentum setup with concrete support: VLO is up about 11% over 21 trading days, closed at a 21-day high, and is benefiting from favorable headlines around tight fuel supply, strong crack spreads, robust jet fuel demand, and a Q1 2026 earnings turnaround to $1.3B net income. | Jun 29 – Jul 6 | Active (as of archive) | Open |
LXRX Lexicon Pharmaceuticals, Inc. Healthcare | Legitimate biotech catalyst/momentum trade: LXRX rose about 20% over 21 trading days to a new 21-day high, with clinical progress in sotagliflozin, pilavapadin, SONATA-HCM enrollment, and a planned ZYNQUISTA NDA resubmission by mid-2026, plus about $199.7M cash/investments and a loan facility up to $100M. | Jun 29 – Jul 6 | Active (as of archive) | Open |
MBX MBX Biosciences, Inc. Common Stock Healthcare | High-momentum biotech idea: MBX rose about 70.7% over 21 trading days and about 51% in 10 sessions, with recent canvuparatide Phase 2 Avail and 1-year extension data accepted for ENDO 2026, an investor webcast, Phase 3 expected to start in Q3 2026, and about $440M cash/investments with minimal debt. | Jun 29 – Jul 6 | Active (as of archive) | Open |
QURE uniQure N.V. Healthcare | Speculative but strong catalyst setup: FDA reopening of the AMT-130 path for Huntington's disease created a major positive catalyst, management plans a BLA submission in Q3 2026, and the stock is up about 66% over 21 trading days while remaining near the top of its range. | Jun 29 – Jul 6 | Active (as of archive) | Open |
LQDA Liquidia Corporation Healthcare | Constructive biotech momentum/visibility trade: stock is up about 19% over 21 trading days, supported by roughly $130M in YUTREPIA net product sales, a third straight profitable quarter, more than 4,500 unique prescriptions, S&P SmallCap 600 inclusion, and ongoing PHA conference scientific visibility. | Jun 29 – Jul 6 | Active (as of archive) | Open |
FTNT Fortinet, Inc. Technology | Cybersecurity momentum name with operating support: FTNT rose about 13% over 21 trading days and closed at a new 21-day high on 2026-06-29, while recent updates included a beat versus high-end guidance, raised 2026 revenue guidance, product revenue up 41% YoY, and active AI/security catalysts including FortiGate G-series and NVIDIA-related platform work. | Jun 29 – Jul 6 | Active (as of archive) | Open |
FROG JFrog Ltd. Technology | Software supply-chain security breakout candidate: FROG is up about 12% over 21 trading days and finished at a new 21-day high, supported by being named a leader in the first Magic Quadrant for Software Supply Chain Security, Russell 3000 addition, and AI/security integrations with Cursor, Claude Code, and NanoClaw. | Jun 29 – Jul 6 | Active (as of archive) | Open |
CHYM Chime Financial, Inc. Class A Common Stock Financial Services | Fintech momentum/watchlist candidate with improving fundamentals: Q1 2026 beat the high end of guidance, Chime posted its first GAAP-profitable quarter as a public company, launched Chime Prime, and showed revenue of $647.4M, about 90% gross margin, positive net income, $87.5M operating cash flow, and $80.0M free cash flow while the stock rose about 8.7% over 21 trading days. | Jun 29 – Jul 6 | Active (as of archive) | Open |
AORT Artivion, Inc. Healthcare | Fresh medical-device catalyst with improving operations: AORT received FDA PMA approval for AMDS Hybrid Prosthesis on 2026-06-29 after prior NEXUS Aortic Arch approval on 2026-04-07 and Endospan acquisition completion on 2026-05-18; Q1 2026 revenue rose 18% YoY to $116.3M and adjusted EBITDA rose 26% to $22.1M. | Jun 29 – Jul 6 | Active (as of archive) | Open |
Trust layer
Outcome log
Closed ideas with realised P/L. Winners and losers stay visible.
| Ticker | Window | Outcome | Closed | Link |
|---|---|---|---|---|
MU Micron Technology, Inc. Technology | Jun 18–25 | +7.0% | 2026-06-25 | Open |
BE Bloom Energy Corporation Industrials | Jun 18–25 | -6.0% | 2026-06-25 | Open |
HPE Hewlett Packard Enterprise Company Technology | Jun 18–25 | -1.5% | 2026-06-25 | Open |
QURE uniQure N.V. Healthcare | Jun 18–25 | +6.1% | 2026-06-25 | Open |
ELAN Elanco Animal Health Incorporated Healthcare | Jun 18–25 | +0.6% | 2026-06-25 | Open |
LQDA Liquidia Corporation Healthcare | Jun 18–25 | +8.2% | 2026-06-25 | Open |
CAI Caris Life Sciences, Inc. Healthcare | Jun 18–25 | +1.3% | 2026-06-25 | Open |
CCL Carnival Corporation & plc Consumer Cyclical | Jun 18–25 | -7.8% | 2026-06-25 | Open |
WYFI WhiteFiber, Inc. Ordinary Shares Technology | Jun 18–25 | -4.3% | 2026-06-25 | Open |
MBX MBX Biosciences, Inc. Common Stock Healthcare | Jun 18–25 | +17.1% | 2026-06-25 | Open |
Weekly rating moves
Rating moves
Upgrades and downgrades captured for the week.
Snapshot — week of 2026-06-29
- KRYS8.1Krystal Biotech, Inc. · Healthcare
- CINF8.0Cincinnati Financial Corporation · Financial Services
- ECG8.0Everus Construction Group, Inc. · Industrials
- ILMN8.0Illumina, Inc. · Healthcare
- ASX8.0ASE Technology Holding Co., Ltd. · Technology
- RY8.0Royal Bank of Canada · Financial Services
- LLY8.0Eli Lilly and Company · Healthcare
- V8.0Visa Inc. · Financial Services
- ASML8.0ASML Holding N.V. · Technology
- TSM8.0Taiwan Semiconductor Manufacturing Company Limited · Technology
Quant Lab
Quant strategy tests
One concrete backtest at a time — strategy, universe, period, metric, limitation.
Quant Lab
Latest quant strategy test
Breadth-Aware Sector-Neutral Quality Momentum Long/Short Top 500 US Stocks
BREADTH_AWARE_QUALITY_MOMENTUM_LSquality-momentumlong-shortsector-neutralbreadth-overlay2018-01-01..2023-01-01
- Sharpe
- 0.71
- Total return
- +28.4%
- Max drawdown
- -21.3%
- Volatility
- +8.0%
Breadth-Aware Sector-Neutral Quality Momentum Long/Short Top 500 US Stocks — strategy card Spec ID: spec-breadth-aware-quality-momentum-long-short-top500-us-stocks-1781966836 · Generated: 2026-06-20 15:51 UTC Cluster…
Latest run — Jun 20, 2026. Research artifact, not live performance.
Recently added
- Regime-Adaptive Relative Momentum on Top 100 Most Traded U.S. StocksSharpe 1.08·+46.4%
- Time-Series Momentum w/ Trend Filter + Volatility/Drawdown Crash Protection (US Stocks)Sharpe 0.73·+65.5%
- Correlation-Breakdown Momentum Crash Defender (Winners Crowding Trigger + Defensive Rotation)Sharpe 0.78·+53.0%